336 Two meta-analyses that included findings from 26 and 30 randomized controlled trials involving a total of 10,941 and 11,502 participants, respectively, found TRT in men with hypogonadism did not increase the risks of adverse cardiovascular outcomes, including death due to cardiovascular disease or any cause, heart attack, stroke, congestive heart failure, atrial fibrillation, pulmonary embolism, or venous thrombosis
Endocrine Reviews, 44 , 1432
Stimulates collagen synthesis , crucial for tendon, ligament, and muscle healing
GLP-1 medications can help fill that gap, not just by supporting weight loss but by helping rebuild metabolic resilience